On January 24, 2023, Adaptive Biotechnologies Corporation (NASDAQ: ADPT) opened at $9.29, lower -4.36% from the last session. During the day, the shares moved up to $9.445 and dropped to $8.915 before settling in for the closing price of $9.40. Price fluctuations for ADPT have ranged from $5.95 to $18.02 over the past 52 weeks.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Company’s average yearly earnings per share was noted -32.50% at the time writing. With a float of $140.66 million, this company’s outstanding shares have now reached $142.93 million.
In an organization with 858 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +59.02, operating margin of -135.39, and the pretax margin is -134.31.
Adaptive Biotechnologies Corporation (ADPT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Adaptive Biotechnologies Corporation is 0.20%, while institutional ownership is 89.30%. The most recent insider transaction that took place on Jan 10, was worth 18,275. In this transaction Chief Operating Officer of this company sold 2,130 shares at a rate of $8.58, taking the stock ownership to the 113,518 shares. Before that another transaction happened on Jan 09, when Company’s Chief Operating Officer sold 995 for $8.50, making the entire transaction worth $8,458. This insider now owns 115,648 shares in total.
Adaptive Biotechnologies Corporation (ADPT) Latest Financial update
If we go through the results of last quarter, which was made public on 6/29/2022, the company posted -$0.37 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.43) by $0.06. This company achieved a net margin of -134.30 while generating a return on equity of -30.77. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -32.50% per share during the next fiscal year.
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Trading Performance Indicators
Check out the current performance indicators for Adaptive Biotechnologies Corporation (ADPT). In the past quarter, the stock posted a quick ratio of 5.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.31 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corporation (ADPT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.01 million. That was inferior than the volume of 1.04 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 27.04%. Additionally, its Average True Range was 0.62.
During the past 100 days, Adaptive Biotechnologies Corporation’s (ADPT) raw stochastic average was set at 62.03%, which indicates a significant increase from 45.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.31% in the past 14 days, which was lower than the 96.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.44, while its 200-day Moving Average is $8.59. However, in the short run, Adaptive Biotechnologies Corporation’s stock first resistance to watch stands at $9.32. Second resistance stands at $9.65. The third major resistance level sits at $9.85. If the price goes on to break the first support level at $8.79, it is likely to go to the next support level at $8.59. The third support level lies at $8.26 if the price breaches the second support level.
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Key Stats
There are currently 143,012K shares outstanding in the company with a market cap of 1.26 billion. Presently, the company’s annual sales total 154,340 K according to its annual income of -207,280 K. Last quarter, the company’s sales amounted to 47,830 K and its income totaled -45,280 K.